TDRD3, a Tudor domain-containing protein, regulates <i>Klf2</i>-dependent T<sub>reg</sub> differentiation and function to modulate immune tolerance.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41576154.
- Also identified by DOI 10.1126/sciadv.aea3960 and PMC identifier 12829583.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tudor domain-containing protein 3 (TDRD3) functions as a methylarginine reader that relays posttranslational arginine methylation signals to the transcriptional machinery, thereby regulating cellular functions through modulation of gene expression. Regulatory T cells (T<sub>regs</sub>) are pivotal for establishing and maintaining immune tolerance. In this study, we demonstrate that mice with T<sub>reg</sub>-specific deletion of <i>Tdrd3</i> exhibit severely impaired iT<sub>reg</sub>, but not thymic T<sub>reg</sub>, differentiation. Moreover, iT<sub>regs</sub>, but not thymic T<sub>regs</sub>, derived from these mice fail to suppress colitis in adoptive transfer models, indicating compromised inhibitory capacity. Aged <i>Tdrd3</i>-deficient mice also show spontaneous autoinflammation. Mechanistically, TDRD3 is recruited by the transcription factor FOXO1, presumably in a methylation-dependent manner, to activate <i>Klf2</i> expression, which is essential for T<sub>reg</sub> differentiation. Notably, the enforced expression of <i>Klf2</i> in <i>Tdrd3</i>-deficient CD4<sup>+</sup> T cells rescue both iT<sub>reg</sub> development and suppressive function. Collectively, our findings identify TDRD3 as a central transcriptional regulator of iT<sub>reg</sub> differentiation and immune homeostasis, highlighting it as a potential therapeutic target for modulating immune tolerance.
Medical subject headings
- Kruppel-Like Transcription Factors
- T-Lymphocytes, Regulatory
- Cell Differentiation
- Immune Tolerance